California Cancer Reporting System Standards Volume I: Abstracting and Coding Procedures
The Mets at Diagnosis – Other data item captures any type of distant involvement not captured in the bone, brain, liver, lung, and distant lymph node fields where metastasis has occurred at the time of diagnosis.
Code information about other metastasis only (discontinuous or distant) to other sites identified at the time of diagnosis.
NOTE: Do not code this field for bone, brain, liver, lung, or distant lymph node metastasis.
Metastatic involvement may be single (one focus of metastatic disease) or multiple (multiple foci of metastatic disease in the same site or multiple sites).
Information regarding other involvement may be clinical or pathologic.
Code this field for other metastasis even if the patient had neoadjuvant (preoperative) systemic therapy, unless it is determined to be disease progression.
Code other involvement in this field for all solid tumors, Kaposi’s sarcoma, Lymphomas, Unknown primary site and Other and Ill-defined primary sites.
Code this field for Lymphomas of all sites for the histologies (9590-9699, 9702-9727, 9735, 9737-9738, 9811-9818, 9823, 8927, and 9737).
Assign the code that best describes whether the case has other metastasis at diagnosis.
Use code 0 when the medical record:
Indicates no other sites of distant (discontinuous) metastases. Including:
A negative clinical or pathologic statement
Negative imaging reports
Mentions (discontinuous) metastasis but other sites are not stated as involved.
Use code 1 when the medical record confirms:
The patient has distant (discontinuous) metastasis sites other than bone, brain, liver, lung, or distant lymph nodes are mentioned as involved.
Examples: Include but are not limited to – adrenal gland, bone marrow, pleura, malignant pleural effusion, peritoneum, and skin.
Lymphomas with bone marrow involvement (Stage IV disease)
NOTE: Lymphomas or lymphoma/leukemias where primary site is C421 are NOT coded in this field.
Use code 2 when the medical record:
Indicates patient has carcinomatosis (a condition in which the cancer has spread widely throughout the body, or to a relatively large region of the body)
NOTE: It is possible to have metastatic disease to a specific organ AND also have carcinomatosis. Be sure to code the specific site as well as the carcinomatosis.
Use code 8 (Not applicable) for the following site/histology combinations for which a code for distant metastasis is not clinically relevant:
ICD-O-3 Site |
ICD-O-3 Histology |
Description |
C000-C809 |
9740-9809, 9840-9992 |
Mast cell, histiocytosis, immunoproliferative, leukemias |
C000-C440, C442-C689, C691-C694, C698-C809 |
9820, 9826, 9831-9834, 9731, 9732, 9734 |
Other hematopietic neoplasm coded to any site except eyelid, conjunctiva, lacrimal gland, orbit, and eye overlapping and NOS |
Use code 9 when the patient is known to have distant metastasis but it cannot be determined whether the distant metastasis include other than bone, brain, liver, lung and distant lymph node(s).
Code |
Description |
0 |
None; no other metastasis |
1 |
Yes, distant metastasis in known site(s), other than bone, brain, liver, lung or distant lymph nodes Note: Includes bone marrow involvement for lymphoma |
2 |
Generalized metastasis such as carcinomatosis |
8 |
Not Applicable |
9 |
Unknown whether any other metastatic site or generalized metastasis Not documented in patient record |